Search results

Comparative effectiveness research compares two or more treatments to see which one works better for certain patients. Researchers often use data from patients' electronic health records to compare different treatments. This study addresses some problems that can arise from this practice. In some long-term research studies, researchers use data collected when patients in the studies see their doctors. Regularly scheduled doctor visits, called well visits, include yearly checkups or periodic blood pressure checks. Other doctor visits, called sick visits, occur when a patient feels sick or needs special care.

Well and sick visits can produce different types of health record data. In addition, test results at sick visits may be different from results at well visits. Using data from sick visits may inappropriately influence, or bias, a study's results. Also, patients may go to the doctor more often when they have symptoms or chronic health problems. Researchers may then collect more data from these patients than they collect from the healthier patients. Unequal amounts of data per patient make it harder to compare treatment results.

For this study, the research team created three tests to find if data from sick visits lead to bias in a study's findings. The team also compared standard and newer statistical methods for analyzing data that include sick visits. Researchers designed the newer methods to reduce bias from data obtained at sick visits. With less biased results, doctors can be more certain about which treatment worked better for certain patients.

The Preserving Kidney Function in Children With Chronic Kidney Disease (PRESERVE) study was designed to provide new knowledge to inform shared decision-making regarding blood pressure (BP) management for pediatric chronic kidney disease (CKD). PRESERVE compared the effectiveness of alternative strategies for monitoring and treating hypertension on preserving kidney function; expanded the National Patient-Centered Clinical Research Network (PCORnet) Common Data Model by adding pediatric- and kidney-specific variables and linking electronic health record data to other kidney disease databases; and assessed the lived experiences of patients related to BP management.

Participants were recruited from 15 clinical institutions across the United States. The research team analyzed electronic health record (EHR) data from 11,851 children with CKD and their caregivers to compare different ways to monitor and treat BP to preserve kidney function. In addition, a subset of patients and caregivers completed an online survey detailing patient-reported outcomes, such as fatigue, life satisfaction, pain levels, sleep disturbance, anxiety, and peer relationships (n=395).

Due to the risk of re-identification based on unique patterns in the individual-level PCORnet electronic health record (EHR) data, patient privacy regulations prohibit the public release of the individual-level data. This collection contains the code underlying the analysis; instructions, codesets, and output lists for the PCORnet queries; and the survey questionnaires for patients and family members.

Patients treated for metastatic cancer, or cancer that has spread to another part of the body, often have symptoms from cancer and its treatment. They may feel tired, depressed, or nauseated. They may find it hard to do their usual activities. Better symptom tracking may help improve patients' care. For example, symptom tracking could quickly alert doctors when a patient may need a different medicine. In this study, the research team compared use of a weekly electronic symptom tracking system versus usual care for patients with cancer. Patients receiving usual care could report their symptoms to their care team during regular clinic visits. The research team wanted to see if the tracking system helped patients live longer, have better quality of life, or go to the hospital or emergency room less often. The aims of this study were as follows:

1. Determine whether integrating electronic patient-reported outcomes (ePRO) in cancer care improves patient-centered outcomes;
2. Elicit perspectives about benefit burden tradeoffs for integrating patient-reported outcomes into clinical workflow; and
3. Identify barriers, facilitators, and strategies used by practices to integrate patient-reported outcomes into clinical workflow.

A total of 1,191 patients were enrolled from 52 U.S.-based community oncology practices. Randomization into intervention and control conditions occurred at the site level. Data collected as part of this study included patient clinical information; weekly symptom surveys, quality of life surveys, and cancer care surveys completed by patients; feedback on the ePRO intervention from patients, clinical research associates, nurses, and physicians; and symptom alerts sent to nursing staff. Please note that while qualitative data were collected as part of this study, they are not available.